Emergency use authorization

AstraZeneca says vaccine 76% effective in updated US trial data

AstraZeneca was an early frontrunner in the global race to develop a COVID vaccine, and was heavily favored by the United States

Joint push by Serum Institute, Bharat Biotech to assure people on vaccine efficacy

The chiefs of both firms asserted their intent to jointly develop, manufacture and supply Covid vaccines in India and other nations too

Serum Institute applies for emergency use authorisation for COVID-19 vaccine

The Pune-based company has collaborated with Oxford University and pharmaceutical company Astra Zeneca for making the vaccine

1 of 1